查看购物车
  • Traditional Chinese
  • English
生物製药合约製造市场规模及预测 2021 - 2031、全球及地区份额、趋势及成长机会分析报告涵盖范围：依产品类型、来源、应用、治疗领域及地理划分
市场调查报告书
商品编码
1761162

生物製药合约製造市场规模及预测 2021 - 2031、全球及地区份额、趋势及成长机会分析报告涵盖范围：依产品类型、来源、应用、治疗领域及地理划分

Biopharmaceutical Contract Manufacturing Market Size and Forecast 2021 - 2031, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type, Source, Application, Therapeutic Area, and Geography
出版日期: | 出版商: The Insight Partners | 英文 243 Pages | 订单完成后即时交付

价格

生物製药合约製造市场规模预计将从2024年的409.9亿美元成长到2031年的1,010.5亿美元；预计2025年至2031年期间的复合年增长率将达到13.8%。生物製剂需求的增长以及对成本效益和灵活性的日益增长的需求是推动生物製药合约製造市场规模扩张的重要因素。然而，预算紧缩和经济不确定性阻碍了生物製药合约製造市场的成长。

单株抗体、基因疗法和细胞疗法催生了对更具创新性和更精简的製造流程的需求。因此，合约製造组织 (CMO) 越来越多地采用连续製造、自动化、人工智慧 (AI) 和流程分析技术 (PAT) 等先进技术，以提高生产能力并满足日益增长的生物製药需求。连续製造正在生物製药行业迅速发展，因为它可以实现生物製剂的不间断生产，从而提供更高的一致性、速度和效率。此製程减少了生产运作之间的停机时间，并最大限度地减少了中间储存的需求，从而显着降低了生产成本。根据贝克麦坚时律师事务所的报告，连续製造可将生物製剂生产成本降低 30%。诺华和辉瑞是实施连续製造进行大规模生物製剂生产的主要公司之一，证明了其在提高营运效率和降低成本方面的有效性。

人工智慧 (AI) 还可用于流程优化、预测性维护和品质控制。基于 AI 的工具可以即时分析大量生产资料，在潜在问题出现之前识别它们，并确保整个生产流程保持最佳状态。这项技术可帮助合约生产组织 (CMO) 最大限度地减少停机时间并提高良率。像 Cognizant 这样的公司已经在使用 AI 来预测製造过程中的潜在故障并改善决策。此外，製程分析技术 (PAT) 能够即时监控和控制关键製程参数，确保大批量生物製剂的品质始终如一。透过整合 PAT，製造商可以在生产过程的早期发现变化并即时调整以防止缺陷或不一致。这可以提高产品品质并更有效地利用资源，从而节省时间和成本。因此，预计连续製造、自动化、人工智慧和 PAT 等先进製造技术的日益普及将在未来几年促进生物製药合约製造市场的成长。

基于治疗领域的见解

根据治疗领域，生物製药合约製造市场细分为肿瘤学、自体免疫疾病、呼吸系统疾病、代谢性疾病、神经病学、传染病等。肿瘤学领域在 2024 年占据了生物製药合约製造市场的最大份额。由于癌症仍然是全球最大的死亡原因，它推动了对晚期癌症治疗的需求。根据世界卫生组织 (WHO) 报告，2022 年全球报告了 2,000 万例新发癌症病例和 970 万例癌症相关死亡病例。这种需求主要由生物製剂的开发所驱动，而生物製剂的生产涉及复杂的细胞培养系统和严格的品质控制措施，因此对许多製药公司来说，外包给合约製造商是一个可行的解决方案。 Keytruda 在 2024 年的销售额为 294.8 亿美元，凸显了肿瘤生物製剂的巨大市场潜力。此外，个人化肿瘤治疗的日益流行，尤其是CAR-T疗法，例如Kymriah（tisagenlecleucel）和Yescarta（axicabtagene ciloleucel），也推动了对高度专业化的合约生产的需求。这些治疗需要生产基因改造免疫细胞，这催生了对拥有细胞和基因治疗专业知识的CMO的需求，从而推动了生物製药合约生产市场的成长。

世界卫生组织 (WHO)、全球自体免疫研究所 2022 年报告和国际糖尿病联合会是编写生物製药合约製造市场报告时参考的主要和次要来源。

目录

第一章：简介

第二章：执行摘要

  • 分析师市场展望

第三章：研究方法

  • 二次研究
  • 初步研究
    • 假设表述：
    • 宏观经济因素分析：
    • 显影基数：
    • 数据三角测量：
    • 国家级资料：
  • 假设和局限性

第四章：生物製药合约製造市场格局

  • 概述
  • PEST分析

第五章：生物製药合约製造市场－关键市场动态

  • 生物製药合约製造市场－关键市场动态
  • 市场驱动因素：
    • 生物製剂需求不断成长
    • 对成本效率和灵活性的需求不断增加
  • 市场限制
    • 预算紧缩和经济不确定性
  • 市场机会
    • 个人化医疗需求日益增长
  • 未来趋势
    • 先进製造技术
  • 驱动因素和限制因素的影响：

第六章：生物製药合约製造市场-全球市场分析

  • 2021-2031年生物製药合约製造市场收入
  • 生物製药合约製造市场预测分析

第七章：生物製药合约製造市场分析－依产品类型

  • 生物製剂
  • 生物相似药

第 8 章：生物製药合约製造市场分析 - 按来源

  • 微生物
  • 哺乳动物

第九章：生物製药合约製造市场分析—依应用

  • 商业的
  • 临床

第 10 章：生物製药合约製造市场分析 - 按治疗领域

  • 肿瘤学
  • 自体免疫疾病
  • 呼吸系统疾病
  • 代谢紊乱
  • 神经病学
  • 传染病
  • 其他的

第 11 章：生物製药合约製造市场 - 地理分析

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 亚太地区其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 南非
    • 阿拉伯聯合大公国
    • 中东和非洲其他地区
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地区

第 12 章：竞争格局

  • 关键参与者的热图分析
  • 公司定位与集中度

第十三章：产业格局

  • 概述
  • 扩张
  • 新产品开发
  • 合併与收购
  • 合作伙伴关係
  • 其他商业策略

第 14 章：公司简介

  • Boehringer Ingelheim International GmbH
  • Lonza Group AG
  • Samsung Biologics Co Ltd
  • Merck KGaA
  • AbbVie Inc
  • WuXi Biologics Inc
  • Ajinomoto Co Inc
  • Cytiva
  • AGC Biologics AS

第 15 章：附录

Product Code: TIPRE00005512

The biopharmaceutical contract manufacturing market size is expected to grow from US$ 40.99 billion in 2024 to US$ 101.05 billion by 2031; it is projected to register a CAGR of 13.8% during 2025-2031. Rising demand for biologics and increasing demand for cost efficiency and flexibility are noteworthy factors contributing to the expansion of the biopharmaceutical contract manufacturing market size. However, the tightened budget and economic uncertainty hinder the biopharmaceutical contract manufacturing market growth.

Monoclonal antibodies, gene therapies, and cell-based treatments have created the need for more innovative, streamlined manufacturing processes. As a result, contract manufacturing organizations (CMOs) are increasingly adopting advanced technologies such as continuous manufacturing, automation, artificial intelligence (AI), and process analytical technologies (PAT) to enhance production capabilities and meet the growing demand for biopharmaceuticals. Continuous manufacturing is rapidly gaining traction in the biopharmaceutical industry as it allows the uninterrupted production of biologics, providing greater consistency, speed, and efficiency. This process reduces downtime between production runs and minimizes the need for intermediate storage, significantly reducing production costs. According to a Baker McKenzie report, continuous manufacturing can reduce the cost of biologic production by 30%. Novartis and Pfizer are among the major companies implementing continuous manufacturing for large-scale biologic production, demonstrating its effectiveness in improving operational efficiency and reducing costs.

Artificial intelligence (AI) can also be used for process optimization, predictive maintenance, and quality control. AI-based tools can analyze vast amounts of production data in real-time, identifying potential issues before they arise and ensuring optimal conditions throughout the production process. This technology helps CMOs minimize downtime and improve yield rates. Companies such as Cognizant are already using AI to predict potential failures in manufacturing processes and improve decision-making. Furthermore, process analytical technologies (PAT) enable real-time monitoring and control of critical process parameters, ensuring consistent quality across large batches of biologics. By integrating PAT, manufacturers can detect variations early in the production process and adjust in real-time to prevent defects or inconsistencies. This results in higher-quality products and more efficient use of resources, reducing both time and cost. Therefore, the increasing adoption of advanced manufacturing technologies such as continuous manufacturing, automation, AI, and PAT is expected to contribute to the growth of the biopharmaceutical contract manufacturing market in the coming years.

Therapeutic Area-Based Insights

Based on the therapeutic area, the biopharmaceutical contract manufacturing market is segmented into oncology, autoimmune disorders, respiratory disorders, metabolic disorders, neurology, infectious diseases, and others. The oncology segment held the largest biopharmaceutical contract manufacturing market share in 2024. As cancer remains a leading cause of death globally, it drives the need for advanced cancer treatments. According to the World Health Organization (WHO), 20 million new cancer cases and 9.7 million cancer-related deaths were reported globally in 2022. This demand is primarily driven by the development of biologics and the production of biologics involves complex cell culture systems and stringent quality control measures, making outsourcing to contract manufacturers a viable solution for many pharmaceutical companies. Keytruda generated US$ 29.48 billion in sales in 2024, highlighting the immense market potential of oncology biologics. Additionally, the increasing trend toward personalized oncology treatments, particularly with CAR-T therapies such as Kymriah (tisagenlecleucel) and Yescarta (axicabtagene ciloleucel), has also fueled the need for highly specialized contract manufacturing. These treatments require the production of genetically modified immune cells, which creates the demand for CMOs with expertise in cell and gene therapies, thereby fueling the biopharmaceutical contract manufacturing market growth.

World Health Organization (WHO), Global Autoimmune Institute 2022 report, and International Diabetes Federation are among the primary and secondary sources referred to while preparing the biopharmaceutical contract manufacturing market report.

Table Of Contents

1. Introduction

  • 1.1 Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Analyst Market Outlook

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:
  • 3.3 Assumptions and Limitations

4. Biopharmaceutical Contract Manufacturing Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis

5. Biopharmaceutical Contract Manufacturing Market - Key Market Dynamics

  • 5.1 Biopharmaceutical Contract Manufacturing Market - Key Market Dynamics
  • 5.2 Market Drivers:
    • 5.2.1 Rising Demand for Biologics
    • 5.2.2 Increasing Demand for Cost Efficiency and Flexibility
  • 5.3 Market Restraints
    • 5.3.1 Tightened Budget and Economic Uncertainty
  • 5.4 Market Opportunities
    • 5.4.1 Increasing Demand for Personalized Medicine
  • 5.5 Future Trends
    • 5.5.1 Advanced Manufacturing Technologies
  • 5.6 Impact of Drivers and Restraints:

6. Biopharmaceutical Contract Manufacturing Market - Global Market Analysis

  • 6.1 Biopharmaceutical Contract Manufacturing Market Revenue (US$ Million), 2021-2031
  • 6.2 Biopharmaceutical Contract Manufacturing Market Forecast Analysis

7. Biopharmaceutical Contract Manufacturing Market Analysis - by Product Type

  • 7.1 Biologics
    • 7.1.1 Overview
    • 7.1.2 Biologics: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.2 Biosimilar
    • 7.2.1 Overview
    • 7.2.2 Biosimilar: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)

8. Biopharmaceutical Contract Manufacturing Market Analysis - by Source

  • 8.1 Microbial
    • 8.1.1 Overview
    • 8.1.2 Microbial: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.2 Mammalian
    • 8.2.1 Overview
    • 8.2.2 Mammalian: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)

9. Biopharmaceutical Contract Manufacturing Market Analysis - by Application

  • 9.1 Commercial
    • 9.1.1 Overview
    • 9.1.2 Commercial: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.2 Clinical
    • 9.2.1 Overview
    • 9.2.2 Clinical: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)

10. Biopharmaceutical Contract Manufacturing Market Analysis - by Therapeutic Area

  • 10.1 Oncology
    • 10.1.1 Overview
    • 10.1.2 Oncology: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.2 Autoimmune Disorders
    • 10.2.1 Overview
    • 10.2.2 Autoimmune Disorders: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.3 Respiratory Disorders
    • 10.3.1 Overview
    • 10.3.2 Respiratory Disorders: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.4 Metabolic Disorders
    • 10.4.1 Overview
    • 10.4.2 Metabolic Disorders: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.5 Neurology
    • 10.5.1 Overview
    • 10.5.2 Neurology: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.6 Infectious Diseases
    • 10.6.1 Overview
    • 10.6.2 Infectious Diseases: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.7 Others
    • 10.7.1 Overview
    • 10.7.2 Others: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)

11. Biopharmaceutical Contract Manufacturing Market - Geographical Analysis

  • 11.1 North America
    • 11.1.1 North America Biopharmaceutical Contract Manufacturing Market Overview
    • 11.1.2 North America: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2031 (US$ Million)
      • 11.1.2.1 North America: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast Analysis - by Product Type
      • 11.1.2.2 North America: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast Analysis - by Source
      • 11.1.2.3 North America: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast Analysis - by Application
      • 11.1.2.4 North America: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast Analysis - by Therapeutic Area
    • 11.1.3 North America: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast Analysis - by Country
      • 11.1.3.1 United States: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.1.3.1.1 United States: Biopharmaceutical Contract Manufacturing Market Breakdown, by Product Type
        • 11.1.3.1.2 United States: Biopharmaceutical Contract Manufacturing Market Breakdown, by Source
        • 11.1.3.1.3 United States: Biopharmaceutical Contract Manufacturing Market Breakdown, by Application
        • 11.1.3.1.4 United States: Biopharmaceutical Contract Manufacturing Market Breakdown, by Therapeutic Area
      • 11.1.3.2 Canada: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.1.3.2.1 Canada: Biopharmaceutical Contract Manufacturing Market Breakdown, by Product Type
        • 11.1.3.2.2 Canada: Biopharmaceutical Contract Manufacturing Market Breakdown, by Source
        • 11.1.3.2.3 Canada: Biopharmaceutical Contract Manufacturing Market Breakdown, by Application
        • 11.1.3.2.4 Canada: Biopharmaceutical Contract Manufacturing Market Breakdown, by Therapeutic Area
      • 11.1.3.3 Mexico: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.1.3.3.1 Mexico: Biopharmaceutical Contract Manufacturing Market Breakdown, by Product Type
        • 11.1.3.3.2 Mexico: Biopharmaceutical Contract Manufacturing Market Breakdown, by Source
        • 11.1.3.3.3 Mexico: Biopharmaceutical Contract Manufacturing Market Breakdown, by Application
        • 11.1.3.3.4 Mexico: Biopharmaceutical Contract Manufacturing Market Breakdown, by Therapeutic Area
  • 11.2 Europe
    • 11.2.1 Europe Biopharmaceutical Contract Manufacturing Market Overview
    • 11.2.2 Europe: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2031 (US$ Million)
      • 11.2.2.1 Europe: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast Analysis - by Product Type
      • 11.2.2.2 Europe: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast Analysis - by Source
      • 11.2.2.3 Europe: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast Analysis - by Application
      • 11.2.2.4 Europe: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast Analysis - by Therapeutic Area
    • 11.2.3 Europe: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast Analysis - by Country
      • 11.2.3.1 Germany: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.2.3.1.1 Germany: Biopharmaceutical Contract Manufacturing Market Breakdown, by Product Type
        • 11.2.3.1.2 Germany: Biopharmaceutical Contract Manufacturing Market Breakdown, by Source
        • 11.2.3.1.3 Germany: Biopharmaceutical Contract Manufacturing Market Breakdown, by Application
        • 11.2.3.1.4 Germany: Biopharmaceutical Contract Manufacturing Market Breakdown, by Therapeutic Area
      • 11.2.3.2 United Kingdom: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.2.3.2.1 United Kingdom: Biopharmaceutical Contract Manufacturing Market Breakdown, by Product Type
        • 11.2.3.2.2 United Kingdom: Biopharmaceutical Contract Manufacturing Market Breakdown, by Source
        • 11.2.3.2.3 United Kingdom: Biopharmaceutical Contract Manufacturing Market Breakdown, by Application
        • 11.2.3.2.4 United Kingdom: Biopharmaceutical Contract Manufacturing Market Breakdown, by Therapeutic Area
      • 11.2.3.3 France: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.2.3.3.1 France: Biopharmaceutical Contract Manufacturing Market Breakdown, by Product Type
        • 11.2.3.3.2 France: Biopharmaceutical Contract Manufacturing Market Breakdown, by Source
        • 11.2.3.3.3 France: Biopharmaceutical Contract Manufacturing Market Breakdown, by Application
        • 11.2.3.3.4 France: Biopharmaceutical Contract Manufacturing Market Breakdown, by Therapeutic Area
      • 11.2.3.4 Italy: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.2.3.4.1 Italy: Biopharmaceutical Contract Manufacturing Market Breakdown, by Product Type
        • 11.2.3.4.2 Italy: Biopharmaceutical Contract Manufacturing Market Breakdown, by Source
        • 11.2.3.4.3 Italy: Biopharmaceutical Contract Manufacturing Market Breakdown, by Application
        • 11.2.3.4.4 Italy: Biopharmaceutical Contract Manufacturing Market Breakdown, by Therapeutic Area
      • 11.2.3.5 Spain: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.2.3.5.1 Spain: Biopharmaceutical Contract Manufacturing Market Breakdown, by Product Type
        • 11.2.3.5.2 Spain: Biopharmaceutical Contract Manufacturing Market Breakdown, by Source
        • 11.2.3.5.3 Spain: Biopharmaceutical Contract Manufacturing Market Breakdown, by Application
        • 11.2.3.5.4 Spain: Biopharmaceutical Contract Manufacturing Market Breakdown, by Therapeutic Area
      • 11.2.3.6 Rest of Europe: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.2.3.6.1 Rest of Europe: Biopharmaceutical Contract Manufacturing Market Breakdown, by Product Type
        • 11.2.3.6.2 Rest of Europe: Biopharmaceutical Contract Manufacturing Market Breakdown, by Source
        • 11.2.3.6.3 Rest of Europe: Biopharmaceutical Contract Manufacturing Market Breakdown, by Application
        • 11.2.3.6.4 Rest of Europe: Biopharmaceutical Contract Manufacturing Market Breakdown, by Therapeutic Area
  • 11.3 Asia Pacific
    • 11.3.1 Asia Pacific Biopharmaceutical Contract Manufacturing Market Overview
    • 11.3.2 Asia Pacific: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2031 (US$ Million)
      • 11.3.2.1 Asia Pacific: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast Analysis - by Product Type
      • 11.3.2.2 Asia Pacific: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast Analysis - by Source
      • 11.3.2.3 Asia Pacific: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast Analysis - by Application
      • 11.3.2.4 Asia Pacific: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast Analysis - by Therapeutic Area
    • 11.3.3 Asia Pacific: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast Analysis - by Country
      • 11.3.3.1 China: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.3.3.1.1 China: Biopharmaceutical Contract Manufacturing Market Breakdown, by Product Type
        • 11.3.3.1.2 China: Biopharmaceutical Contract Manufacturing Market Breakdown, by Source
        • 11.3.3.1.3 China: Biopharmaceutical Contract Manufacturing Market Breakdown, by Application
        • 11.3.3.1.4 China: Biopharmaceutical Contract Manufacturing Market Breakdown, by Therapeutic Area
      • 11.3.3.2 Japan: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.3.3.2.1 Japan: Biopharmaceutical Contract Manufacturing Market Breakdown, by Product Type
        • 11.3.3.2.2 Japan: Biopharmaceutical Contract Manufacturing Market Breakdown, by Source
        • 11.3.3.2.3 Japan: Biopharmaceutical Contract Manufacturing Market Breakdown, by Application
        • 11.3.3.2.4 Japan: Biopharmaceutical Contract Manufacturing Market Breakdown, by Therapeutic Area
      • 11.3.3.3 India: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.3.3.3.1 India: Biopharmaceutical Contract Manufacturing Market Breakdown, by Product Type
        • 11.3.3.3.2 India: Biopharmaceutical Contract Manufacturing Market Breakdown, by Source
        • 11.3.3.3.3 India: Biopharmaceutical Contract Manufacturing Market Breakdown, by Application
        • 11.3.3.3.4 India: Biopharmaceutical Contract Manufacturing Market Breakdown, by Therapeutic Area
      • 11.3.3.4 Australia: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.3.3.4.1 Australia: Biopharmaceutical Contract Manufacturing Market Breakdown, by Product Type
        • 11.3.3.4.2 Australia: Biopharmaceutical Contract Manufacturing Market Breakdown, by Source
        • 11.3.3.4.3 Australia: Biopharmaceutical Contract Manufacturing Market Breakdown, by Application
        • 11.3.3.4.4 Australia: Biopharmaceutical Contract Manufacturing Market Breakdown, by Therapeutic Area
      • 11.3.3.5 South Korea: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.3.3.5.1 South Korea: Biopharmaceutical Contract Manufacturing Market Breakdown, by Product Type
        • 11.3.3.5.2 South Korea: Biopharmaceutical Contract Manufacturing Market Breakdown, by Source
        • 11.3.3.5.3 South Korea: Biopharmaceutical Contract Manufacturing Market Breakdown, by Application
        • 11.3.3.5.4 South Korea: Biopharmaceutical Contract Manufacturing Market Breakdown, by Therapeutic Area
      • 11.3.3.6 Rest of APAC: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.3.3.6.1 Rest of APAC: Biopharmaceutical Contract Manufacturing Market Breakdown, by Product Type
        • 11.3.3.6.2 Rest of APAC: Biopharmaceutical Contract Manufacturing Market Breakdown, by Source
        • 11.3.3.6.3 Rest of APAC: Biopharmaceutical Contract Manufacturing Market Breakdown, by Application
        • 11.3.3.6.4 Rest of APAC: Biopharmaceutical Contract Manufacturing Market Breakdown, by Therapeutic Area
  • 11.4 Middle East & Africa
    • 11.4.1 Middle East & Africa Biopharmaceutical Contract Manufacturing Market Overview
    • 11.4.2 Middle East & Africa: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2031 (US$ Million)
      • 11.4.2.1 Middle East & Africa: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast Analysis - by Product Type
      • 11.4.2.2 Middle East & Africa: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast Analysis - by Source
      • 11.4.2.3 Middle East & Africa: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast Analysis - by Application
      • 11.4.2.4 Middle East & Africa: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast Analysis - by Therapeutic Area
    • 11.4.3 Middle East & Africa: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast Analysis - by Country
      • 11.4.3.1 Saudi Arabia: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.4.3.1.1 Saudi Arabia: Biopharmaceutical Contract Manufacturing Market Breakdown, by Product Type
        • 11.4.3.1.2 Saudi Arabia: Biopharmaceutical Contract Manufacturing Market Breakdown, by Source
        • 11.4.3.1.3 Saudi Arabia: Biopharmaceutical Contract Manufacturing Market Breakdown, by Application
        • 11.4.3.1.4 Saudi Arabia: Biopharmaceutical Contract Manufacturing Market Breakdown, by Therapeutic Area
      • 11.4.3.2 South Africa: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.4.3.2.1 South Africa: Biopharmaceutical Contract Manufacturing Market Breakdown, by Product Type
        • 11.4.3.2.2 South Africa: Biopharmaceutical Contract Manufacturing Market Breakdown, by Source
        • 11.4.3.2.3 South Africa: Biopharmaceutical Contract Manufacturing Market Breakdown, by Application
        • 11.4.3.2.4 South Africa: Biopharmaceutical Contract Manufacturing Market Breakdown, by Therapeutic Area
      • 11.4.3.3 United Arab Emirates: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.4.3.3.1 United Arab Emirates: Biopharmaceutical Contract Manufacturing Market Breakdown, by Product Type
        • 11.4.3.3.2 United Arab Emirates: Biopharmaceutical Contract Manufacturing Market Breakdown, by Source
        • 11.4.3.3.3 United Arab Emirates: Biopharmaceutical Contract Manufacturing Market Breakdown, by Application
        • 11.4.3.3.4 United Arab Emirates: Biopharmaceutical Contract Manufacturing Market Breakdown, by Therapeutic Area
      • 11.4.3.4 Rest of Middle East & Africa: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.4.3.4.1 Rest of Middle East & Africa: Biopharmaceutical Contract Manufacturing Market Breakdown, by Product Type
        • 11.4.3.4.2 Rest of Middle East & Africa: Biopharmaceutical Contract Manufacturing Market Breakdown, by Source
        • 11.4.3.4.3 Rest of Middle East & Africa: Biopharmaceutical Contract Manufacturing Market Breakdown, by Application
        • 11.4.3.4.4 Rest of Middle East & Africa: Biopharmaceutical Contract Manufacturing Market Breakdown, by Therapeutic Area
  • 11.5 South & Central America
    • 11.5.1 South & Central America Biopharmaceutical Contract Manufacturing Market Overview
    • 11.5.2 South & Central America: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2031 (US$ Million)
      • 11.5.2.1 South & Central America: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast Analysis - by Product Type
      • 11.5.2.2 South & Central America: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast Analysis - by Source
      • 11.5.2.3 South & Central America: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast Analysis - by Application
      • 11.5.2.4 South & Central America: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast Analysis - by Therapeutic Area
    • 11.5.3 South & Central America: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast Analysis - by Country
      • 11.5.3.1 Brazil: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.5.3.1.1 Brazil: Biopharmaceutical Contract Manufacturing Market Breakdown, by Product Type
        • 11.5.3.1.2 Brazil: Biopharmaceutical Contract Manufacturing Market Breakdown, by Source
        • 11.5.3.1.3 Brazil: Biopharmaceutical Contract Manufacturing Market Breakdown, by Application
        • 11.5.3.1.4 Brazil: Biopharmaceutical Contract Manufacturing Market Breakdown, by Therapeutic Area
      • 11.5.3.2 Argentina: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.5.3.2.1 Argentina: Biopharmaceutical Contract Manufacturing Market Breakdown, by Product Type
        • 11.5.3.2.2 Argentina: Biopharmaceutical Contract Manufacturing Market Breakdown, by Source
        • 11.5.3.2.3 Argentina: Biopharmaceutical Contract Manufacturing Market Breakdown, by Application
        • 11.5.3.2.4 Argentina: Biopharmaceutical Contract Manufacturing Market Breakdown, by Therapeutic Area
      • 11.5.3.3 Rest of South & Central America: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 11.5.3.3.1 Rest of South & Central America: Biopharmaceutical Contract Manufacturing Market Breakdown, by Product Type
        • 11.5.3.3.2 Rest of South & Central America: Biopharmaceutical Contract Manufacturing Market Breakdown, by Source
        • 11.5.3.3.3 Rest of South & Central America: Biopharmaceutical Contract Manufacturing Market Breakdown, by Application
        • 11.5.3.3.4 Rest of South & Central America: Biopharmaceutical Contract Manufacturing Market Breakdown, by Therapeutic Area

12. Competitive Landscape

  • 12.1 Heat Map Analysis by Key Players
  • 12.2 Company Positioning & Concentration

13. Industry Landscape

  • 13.1 Overview
  • 13.2 Expansion
  • 13.3 New Product Development
  • 13.4 Merger and Acquisition
  • 13.5 Partnerships
  • 13.6 Other Business Strategies

14. Company Profiles

  • 14.1 Boehringer Ingelheim International GmbH
    • 14.1.1 Key Facts
    • 14.1.2 Business Description
    • 14.1.3 Products and Services
    • 14.1.4 Financial Overview
    • 14.1.5 SWOT Analysis
    • 14.1.6 Key Developments
  • 14.2 Lonza Group AG
    • 14.2.1 Key Facts
    • 14.2.2 Business Description
    • 14.2.3 Products and Services
    • 14.2.4 Financial Overview
    • 14.2.5 SWOT Analysis
    • 14.2.6 Key Developments
  • 14.3 Samsung Biologics Co Ltd
    • 14.3.1 Key Facts
    • 14.3.2 Business Description
    • 14.3.3 Products and Services
    • 14.3.4 Financial Overview
    • 14.3.5 SWOT Analysis
    • 14.3.6 Key Developments
  • 14.4 Merck KGaA
    • 14.4.1 Key Facts
    • 14.4.2 Business Description
    • 14.4.3 Products and Services
    • 14.4.4 Financial Overview
    • 14.4.5 SWOT Analysis
    • 14.4.6 Key Developments
  • 14.5 AbbVie Inc
    • 14.5.1 Key Facts
    • 14.5.2 Business Description
    • 14.5.3 Products and Services
    • 14.5.4 Financial Overview
    • 14.5.5 SWOT Analysis
    • 14.5.6 Key Developments
  • 14.6 WuXi Biologics Inc
    • 14.6.1 Key Facts
    • 14.6.2 Business Description
    • 14.6.3 Products and Services
    • 14.6.4 Financial Overview
    • 14.6.5 SWOT Analysis
    • 14.6.6 Key Developments
  • 14.7 Ajinomoto Co Inc
    • 14.7.1 Key Facts
    • 14.7.2 Business Description
    • 14.7.3 Products and Services
    • 14.7.4 Financial Overview
    • 14.7.5 SWOT Analysis
    • 14.7.6 Key Developments
  • 14.8 Cytiva
    • 14.8.1 Key Facts
    • 14.8.2 Business Description
    • 14.8.3 Products and Services
    • 14.8.4 Financial Overview
    • 14.8.5 SWOT Analysis
    • 14.8.6 Key Developments
  • 14.9 AGC Biologics AS
    • 14.9.1 Key Facts
    • 14.9.2 Business Description
    • 14.9.3 Products and Services
    • 14.9.4 Financial Overview
    • 14.9.5 SWOT Analysis
    • 14.9.6 Key Developments

15. Appendix

  • 15.1 About The Insight Partners
  • 15.2 Glossary of Terms

List Of Tables

  • Table 1. Biopharmaceutical Contract Manufacturing Market Segmentation
  • Table 2. North America: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 3. North America: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 4. North America: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Source
  • Table 5. North America: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Source
  • Table 6. North America: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 7. North America: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 8. North America: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Area
  • Table 9. North America: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Area
  • Table 10. United States: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 11. United States: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 12. United States: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Source
  • Table 13. United States: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Source
  • Table 14. United States: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 15. United States: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 16. United States: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Area
  • Table 17. United States: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Area
  • Table 18. Canada: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 19. Canada: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 20. Canada: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Source
  • Table 21. Canada: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Source
  • Table 22. Canada: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 23. Canada: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 24. Canada: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Area
  • Table 25. Canada: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Area
  • Table 26. Mexico: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 27. Mexico: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 28. Mexico: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Source
  • Table 29. Mexico: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Source
  • Table 30. Mexico: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 31. Mexico: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 32. Mexico: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Area
  • Table 33. Mexico: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Area
  • Table 34. Europe: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 35. Europe: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 36. Europe: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Source
  • Table 37. Europe: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Source
  • Table 38. Europe: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 39. Europe: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 40. Europe: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Area
  • Table 41. Europe: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Area
  • Table 42. Germany: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 43. Germany: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 44. Germany: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Source
  • Table 45. Germany: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Source
  • Table 46. Germany: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 47. Germany: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 48. Germany: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Area
  • Table 49. Germany: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Area
  • Table 50. United Kingdom: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 51. United Kingdom: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 52. United Kingdom: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Source
  • Table 53. United Kingdom: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Source
  • Table 54. United Kingdom: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 55. United Kingdom: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 56. United Kingdom: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Area
  • Table 57. United Kingdom: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Area
  • Table 58. France: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 59. France: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 60. France: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Source
  • Table 61. France: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Source
  • Table 62. France: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 63. France: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 64. France: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Area
  • Table 65. France: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Area
  • Table 66. Italy: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 67. Italy: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 68. Italy: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Source
  • Table 69. Italy: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Source
  • Table 70. Italy: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 71. Italy: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 72. Italy: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Area
  • Table 73. Italy: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Area
  • Table 74. Spain: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 75. Spain: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 76. Spain: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Source
  • Table 77. Spain: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Source
  • Table 78. Spain: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 79. Spain: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 80. Spain: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Area
  • Table 81. Spain: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Area
  • Table 82. Rest of Europe: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 83. Rest of Europe: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 84. Rest of Europe: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Source
  • Table 85. Rest of Europe: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Source
  • Table 86. Rest of Europe: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 87. Rest of Europe: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 88. Rest of Europe: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Area
  • Table 89. Rest of Europe: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Area
  • Table 90. Asia Pacific: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 91. Asia Pacific: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 92. Asia Pacific: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Source
  • Table 93. Asia Pacific: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Source
  • Table 94. Asia Pacific: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 95. Asia Pacific: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 96. Asia Pacific: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Area
  • Table 97. Asia Pacific: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Area
  • Table 98. China: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 99. China: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 100. China: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Source
  • Table 101. China: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Source
  • Table 102. China: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 103. China: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 104. China: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Area
  • Table 105. China: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Area
  • Table 106. Japan: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 107. Japan: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 108. Japan: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Source
  • Table 109. Japan: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Source
  • Table 110. Japan: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 111. Japan: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 112. Japan: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Area
  • Table 113. Japan: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Area
  • Table 114. India: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 115. India: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 116. India: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Source
  • Table 117. India: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Source
  • Table 118. India: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 119. India: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 120. India: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Area
  • Table 121. India: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Area
  • Table 122. Australia: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 123. Australia: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 124. Australia: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Source
  • Table 125. Australia: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Source
  • Table 126. Australia: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 127. Australia: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 128. Australia: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Area
  • Table 129. Australia: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Area
  • Table 130. South Korea: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 131. South Korea: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 132. South Korea: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Source
  • Table 133. South Korea: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Source
  • Table 134. South Korea: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 135. South Korea: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 136. South Korea: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Area
  • Table 137. South Korea: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Area
  • Table 138. Rest of APAC: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 139. Rest of APAC: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 140. Rest of APAC: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Source
  • Table 141. Rest of APAC: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Source
  • Table 142. Rest of APAC: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 143. Rest of APAC: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 144. Rest of APAC: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Area
  • Table 145. Rest of APAC: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Area
  • Table 146. Middle East & Africa: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 147. Middle East & Africa: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 148. Middle East & Africa: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Source
  • Table 149. Middle East & Africa: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Source
  • Table 150. Middle East & Africa: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 151. Middle East & Africa: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 152. Middle East & Africa: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Area
  • Table 153. Middle East & Africa: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Area
  • Table 154. Saudi Arabia: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 155. Saudi Arabia: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 156. Saudi Arabia: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Source
  • Table 157. Saudi Arabia: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Source
  • Table 158. Saudi Arabia: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 159. Saudi Arabia: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 160. Saudi Arabia: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Area
  • Table 161. Saudi Arabia: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Area
  • Table 162. South Africa: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 163. South Africa: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 164. South Africa: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Source
  • Table 165. South Africa: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Source
  • Table 166. South Africa: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 167. South Africa: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 168. South Africa: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Area
  • Table 169. South Africa: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Area
  • Table 170. United Arab Emirates: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 171. United Arab Emirates: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 172. United Arab Emirates: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Source
  • Table 173. United Arab Emirates: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Source
  • Table 174. United Arab Emirates: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 175. United Arab Emirates: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 176. United Arab Emirates: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Area
  • Table 177. United Arab Emirates: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Area
  • Table 178. Rest of Middle East & Africa: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 179. Rest of Middle East & Africa: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 180. Rest of Middle East & Africa: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Source
  • Table 181. Rest of Middle East & Africa: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Source
  • Table 182. Rest of Middle East & Africa: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 183. Rest of Middle East & Africa: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 184. Rest of Middle East & Africa: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Area
  • Table 185. Rest of Middle East & Africa: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Area
  • Table 186. South & Central America: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 187. South & Central America: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 188. South & Central America: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Source
  • Table 189. South & Central America: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Source
  • Table 190. South & Central America: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 191. South & Central America: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 192. South & Central America: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Area
  • Table 193. South & Central America: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Area
  • Table 194. Brazil: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 195. Brazil: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 196. Brazil: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Source
  • Table 197. Brazil: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Source
  • Table 198. Brazil: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 199. Brazil: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 200. Brazil: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Area
  • Table 201. Brazil: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Area
  • Table 202. Argentina: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 203. Argentina: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 204. Argentina: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Source
  • Table 205. Argentina: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Source
  • Table 206. Argentina: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 207. Argentina: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 208. Argentina: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Area
  • Table 209. Argentina: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Area
  • Table 210. Rest of South & Central America: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Product Type
  • Table 211. Rest of South & Central America: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Product Type
  • Table 212. Rest of South & Central America: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Source
  • Table 213. Rest of South & Central America: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Source
  • Table 214. Rest of South & Central America: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Application
  • Table 215. Rest of South & Central America: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Application
  • Table 216. Rest of South & Central America: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2024 (US$ Million) - by Therapeutic Area
  • Table 217. Rest of South & Central America: Biopharmaceutical Contract Manufacturing Market - Revenue Forecast, 2025-2031 (US$ Million) - by Therapeutic Area
  • Table 218. Heat Map Analysis by Key Players
  • Table 219. Glossary of Terms, Biopharmaceutical Contract Manufacturing Market

List Of Figures

  • Figure 1. Biopharmaceutical Contract Manufacturing Market Segmentation, by Geography
  • Figure 2. PEST Analysis
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Biopharmaceutical Contract Manufacturing Market Revenue (US$ Million), 2021-2031
  • Figure 5. Biopharmaceutical Contract Manufacturing Market Revenue (US$ Million), 2021-2031
  • Figure 6. Biopharmaceutical Contract Manufacturing Market Share (%) - by Product Type (2024 and 2031)
  • Figure 7. Biologics: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 8. Biosimilar: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 9. Biopharmaceutical Contract Manufacturing Market Share (%) - by Source (2024 and 2031)
  • Figure 10. Microbial: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 11. Mammalian: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 12. Biopharmaceutical Contract Manufacturing Market Share (%) - by Application (2024 and 2031)
  • Figure 13. Commercial: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 14. Clinical: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 15. Biopharmaceutical Contract Manufacturing Market Share (%) - by Therapeutic Area (2024 and 2031)
  • Figure 16. Oncology: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 17. Autoimmune Disorders: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 18. Respiratory Disorders: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 19. Metabolic Disorders: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 20. Neurology: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 21. Infectious Diseases: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 22. Others: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 23. North America: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2031 (US$ Million)
  • Figure 24. North America: Biopharmaceutical Contract Manufacturing Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 25. United States: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 26. Canada: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 27. Mexico: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 28. Europe: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2031 (US$ Million)
  • Figure 29. Europe: Biopharmaceutical Contract Manufacturing Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 30. Germany: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 31. United Kingdom: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 32. France: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 33. Italy: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 34. Spain: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 35. Rest of Europe: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 36. Asia Pacific: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2031 (US$ Million)
  • Figure 37. Asia Pacific: Biopharmaceutical Contract Manufacturing Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 38. China: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 39. Japan: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 40. India: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 41. Australia: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 42. South Korea: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 43. Rest of APAC: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 44. Middle East & Africa: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2031 (US$ Million)
  • Figure 45. Middle East & Africa: Biopharmaceutical Contract Manufacturing Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 46. Saudi Arabia: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 47. South Africa: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 48. United Arab Emirates: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 49. Rest of Middle East & Africa: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 50. South & Central America: Biopharmaceutical Contract Manufacturing Market - Revenue, 2021-2031 (US$ Million)
  • Figure 51. South & Central America: Biopharmaceutical Contract Manufacturing Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 52. Brazil: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 53. Argentina: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 54. Rest of South & Central America: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 55. Company Positioning & Concentration